Agilon Health (NYSE:AGL) Stock Price Down 6.1% – Time to Sell?

Agilon Health, Inc. (NYSE:AGL) traded down 6.1% during mid-day trading on Wednesday . The stock traded as low as $107.75 and last traded at $106.3050. 18,677 shares traded hands during trading, a decline of 95% from the average session volume of 350,562 shares. The stock had previously closed at $113.27.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Benchmark restated a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. Barclays upgraded Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a research note on Tuesday, May 26th. Robert W. Baird increased their price target on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Finally, TD Cowen reissued a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $58.73.

Agilon Health Trading Down 1.5%

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $1.86 billion, a price-to-earnings ratio of -5.17 and a beta of 3.02. The firm has a 50-day moving average of $61.29 and a 200 day moving average of $32.15.

Agilon Health (NYSE:AGL) last posted its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. As a group, equities analysts predict that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Several large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC boosted its stake in Agilon Health by 243.3% during the 1st quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock valued at $2,171,000 after purchasing an additional 355,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Agilon Health by 3.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after purchasing an additional 7,209 shares during the period. Dynamic Technology Lab Private Ltd increased its position in shares of Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after purchasing an additional 10,424 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after purchasing an additional 311,158 shares during the period. Finally, Creative Planning increased its position in shares of Agilon Health by 17.6% during the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock valued at $393,000 after purchasing an additional 25,548 shares during the period.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.